| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.659 | 0.006 | 0.659 | Histamine release inhibitor | 0.458 0.046 DBMET00894 0.483 0.035 DBMET00930 0.594 0.011 DBMET00961 | ||
| 0.652 | 0.004 | 0.652 | 5 Hydroxytryptamine 2 antagonist | 0.203 0.03 DBMET00930 0.572 0.005 DBMET00961 | ||
| 0.646 | 0.005 | 0.646 | 5 Hydroxytryptamine antagonist | 0.199 0.034 DBMET00930 0.525 0.006 DBMET00961 | ||
| 0.59 | 0.003 | 0.59 | Dopamine D1 antagonist | 0.239 0.008 DBMET00930 0.385 0.004 DBMET00961 | ||
| 0.566 | 0.004 | 0.566 | 5 Hydroxytryptamine 2B antagonist | 0.165 0.035 DBMET00930 0.456 0.006 DBMET00961 | ||
| 0.561 | 0.004 | 0.561 | Histamine H1 receptor antagonist | 0.085 0.052 DBMET00894 0.216 0.013 DBMET00930 0.33 0.005 DBMET00961 | ||
| 0.56 | 0.004 | 0.56 | 5 Hydroxytryptamine 2A antagonist | 0.161 0.026 DBMET00930 0.479 0.005 DBMET00961 | ||
| 0.541 | 0.004 | 0.541 | 5 Hydroxytryptamine 2C antagonist | 0.117 0.037 DBMET00930 0.454 0.005 DBMET00961 | ||
| 0.536 | 0.004 | 0.536 | Alpha 2b adrenoreceptor antagonist | 0.201 0.023 DBMET00930 0.472 0.004 DBMET00961 | ||
| 0.477 | 0.008 | 0.477 | Cyclic AMP phosphodiesterase inhibitor | 0.453 0.01 DBMET00894 0.251 0.063 DBMET00930 0.435 0.012 DBMET00961 | ||
| 0.444 | 0.006 | 0.444 | Dopamine antagonist | 0.11 0.035 DBMET00930 0.248 0.015 DBMET00961 | ||
| 0.414 | 0.005 | 0.414 | Alpha 2 adrenoreceptor antagonist | 0.191 0.019 DBMET00930 0.392 0.005 DBMET00961 | ||
| 0.414 | 0.005 | 0.414 | Alpha 2a adrenoreceptor antagonist | 0.143 0.024 DBMET00930 0.401 0.005 DBMET00961 | ||
| 0.409 | 0.007 | 0.409 | Dopamine D2 antagonist | 0.09 0.036 DBMET00930 0.229 0.014 DBMET00961 | ||
| 0.412 | 0.02 | 0.412 | Anticonvulsant | 0.187 0.093 DBMET00930 0.328 0.033 DBMET00961 | ||
| 0.367 | 0.007 | 0.367 | Antihistaminic | 0.294 0.01 DBMET00930 0.226 0.017 DBMET00961 | ||
| 0.356 | 0.008 | 0.356 | 5 Hydroxytryptamine 1 antagonist | 0.08 0.047 DBMET00930 0.235 0.014 DBMET00961 | ||
| 0.355 | 0.007 | 0.355 | Histamine antagonist | 0.269 0.012 DBMET00930 0.213 0.017 DBMET00961 | ||
| 0.315 | 0.012 | 0.315 | Acetylcholine M1 receptor antagonist | 0.259 0.023 DBMET00894 0.234 0.03 DBMET00930 0.236 0.029 DBMET00961 | ||
| 0.386 | 0.09 | 0.386 | Analgesic | 0.321 0.126 DBMET00961 | ||
| 0.3 | 0.013 | 0.3 | Toll-Like receptor 9 antagonist | 0.128 0.079 DBMET00930 0.218 0.029 DBMET00961 | ||
| 0.291 | 0.009 | 0.291 | 5 Hydroxytryptamine 1A antagonist | 0.06 0.053 DBMET00930 0.213 0.014 DBMET00961 | ||
| 0.337 | 0.057 | 0.601 | Spasmolytic | 0.601 0.013 DBMET00894 0.332 0.058 DBMET00930 0.213 0.109 DBMET00961 | DBMET00894 | |
| 0.276 | 0.018 | 0.276 | Alpha adrenoreceptor antagonist | 0.095 0.06 DBMET00930 0.219 0.024 DBMET00961 | ||
| 0.255 | 0.005 | 0.255 | Acetylcholine M4 receptor antagonist | 0.091 0.036 DBMET00894 0.097 0.031 DBMET00930 0.163 0.009 DBMET00961 | ||
| 0.258 | 0.009 | 0.258 | Mediator release inhibitor | 0.184 0.018 DBMET00894 0.109 0.059 DBMET00930 0.234 0.011 DBMET00961 | ||
| 0.239 | 0.008 | 0.239 | Falcipain 2 inhibitor | 0.23 0.009 DBMET00961 | ||
| 0.238 | 0.009 | 0.238 | Falcipain inhibitor | 0.23 0.01 DBMET00961 | ||
| 0.287 | 0.06 | 0.287 | Transcription factor STAT3 inhibitor | 0.252 0.082 DBMET00961 | ||
| 0.288 | 0.063 | 0.288 | Transcription factor STAT inhibitor | 0.235 0.098 DBMET00961 | ||
| 0.222 | 0.009 | 0.222 | Dopamine D3 antagonist | 0.115 0.021 DBMET00961 | ||
| 0.221 | 0.009 | 0.221 | 5 Hydroxytryptamine 1F antagonist | 0.155 0.015 DBMET00930 0.13 0.021 DBMET00961 | ||
| 0.265 | 0.055 | 0.283 | Tyrosine 3 hydroxylase inhibitor | 0.227 0.094 DBMET00930 0.283 0.042 DBMET00961 | DBMET00961 | |
| 0.209 | 0.012 | 0.225 | MAP3K9 inhibitor | 0.159 0.047 DBMET00894 0.204 0.014 DBMET00930 0.225 0.008 DBMET00961 | DBMET00961 | |
| 0.239 | 0.048 | 0.239 | Non-steroidal antiinflammatory agent | 0.141 0.128 DBMET00930 0.231 0.052 DBMET00961 | ||
| 0.204 | 0.023 | 0.275 | Acetylcholine muscarinic antagonist | 0.275 0.011 DBMET00894 0.187 0.028 DBMET00930 0.139 0.051 DBMET00961 | DBMET00894 | |
| 0.177 | 0.004 | 0.177 | 5 Hydroxytryptamine 6 antagonist | 0.074 0.027 DBMET00930 0.166 0.005 DBMET00961 | ||
| 0.191 | 0.022 | 0.191 | Alpha 1 adrenoreceptor antagonist | 0.137 0.032 DBMET00961 | ||
| 0.322 | 0.157 | 0.453 | Apoptosis agonist | 0.453 0.09 DBMET00894 0.286 0.182 DBMET00961 | DBMET00894 | |
| 0.162 | 0.008 | 0.162 | Histamine H2 receptor antagonist | 0.132 0.015 DBMET00961 | ||
| 0.184 | 0.037 | 0.218 | Cholinergic antagonist | 0.218 0.028 DBMET00894 0.165 0.045 DBMET00930 0.137 0.06 DBMET00961 | DBMET00894 | |
| 0.214 | 0.067 | 0.215 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.194 0.081 DBMET00930 0.215 0.066 DBMET00961 | DBMET00961 | |
| 0.178 | 0.037 | 0.204 | Acetylcholine antagonist | 0.204 0.03 DBMET00894 0.157 0.047 DBMET00930 0.132 0.06 DBMET00961 | DBMET00894 | |
| 0.163 | 0.032 | 0.163 | Antiadrenergic | 0.156 0.034 DBMET00961 | ||
| 0.253 | 0.125 | 0.372 | Vasodilator, peripheral | 0.27 0.114 DBMET00894 0.372 0.065 DBMET00930 0.268 0.114 DBMET00961 | DBMET00930 | |
| 0.159 | 0.032 | 0.159 | Adrenaline antagonist | 0.152 0.034 DBMET00961 | ||
| 0.135 | 0.013 | 0.135 | Acetylcholine M2 receptor antagonist | 0.064 0.041 DBMET00930 0.077 0.031 DBMET00961 | ||
| 0.143 | 0.022 | 0.143 | Acetylcholine release stimulant | 0.132 0.031 DBMET00930 0.108 0.071 DBMET00961 | ||
| 0.134 | 0.013 | 0.134 | Acetylcholine M3 receptor antagonist | 0.115 0.015 DBMET00930 0.089 0.022 DBMET00961 | ||
| 0.13 | 0.01 | 0.13 | Acetylcholine M5 receptor antagonist | 0.056 0.049 DBMET00930 0.078 0.025 DBMET00961 | ||
| 0.12 | 0.004 | 0.12 | Histamine H4 receptor antagonist | 0.086 0.007 DBMET00930 0.109 0.005 DBMET00961 | ||
| 0.133 | 0.019 | 0.166 | Alpha adrenoreceptor agonist | 0.064 0.051 DBMET00930 0.166 0.013 DBMET00961 | DBMET00961 | |
| 0.128 | 0.018 | 0.139 | Alpha 2d adrenoreceptor antagonist | 0.122 0.022 DBMET00930 0.139 0.013 DBMET00961 | DBMET00961 | |
| 0.186 | 0.077 | 0.22 | DNA methyltransferase I inhibitor | 0.22 0.059 DBMET00894 0.194 0.072 DBMET00930 0.133 0.125 DBMET00961 | DBMET00894 | |
| 0.122 | 0.014 | 0.122 | MAP3K7 inhibitor | 0.088 0.031 DBMET00930 0.098 0.023 DBMET00961 | ||
| 0.113 | 0.011 | 0.153 | Alpha 2 adrenoreceptor agonist | 0.103 0.014 DBMET00930 0.153 0.006 DBMET00961 | DBMET00961 | |
| 0.214 | 0.115 | 0.214 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.133 | 0.034 | 0.133 | Estrogen antagonist | 0.102 0.095 DBMET00894 0.129 0.039 DBMET00930 0.13 0.038 DBMET00961 | ||
| 0.143 | 0.045 | 0.143 | DNA intercalator | 0.102 0.071 DBMET00894 0.097 0.077 DBMET00930 0.124 0.055 DBMET00961 | ||
| 0.184 | 0.09 | 0.233 | DNA methylase inhibitor | 0.233 0.058 DBMET00894 0.203 0.077 DBMET00930 | DBMET00894 | |
| 0.22 | 0.129 | 0.309 | Hypoxia-inducible factor 1 alpha inhibitor | 0.309 0.062 DBMET00930 0.18 0.178 DBMET00961 | DBMET00930 | |
| 0.112 | 0.023 | 0.147 | 5 Hydroxytryptamine uptake inhibitor | 0.07 0.039 DBMET00930 0.147 0.016 DBMET00961 | DBMET00961 | |
| 0.11 | 0.021 | 0.11 | Alpha 1d adrenoreceptor antagonist | 0.077 0.032 DBMET00961 | ||
| 0.131 | 0.042 | 0.131 | Alpha 2c adrenoreceptor antagonist | 0.12 0.05 DBMET00930 0.097 0.069 DBMET00961 | ||
| 0.094 | 0.007 | 0.098 | Glucose-6-phosphate translocase inhibitor | 0.078 0.012 DBMET00894 0.098 0.006 DBMET00930 0.083 0.01 DBMET00961 | DBMET00930 | |
| 0.119 | 0.033 | 0.119 | Estrogen receptor beta antagonist | 0.118 0.034 DBMET00930 0.116 0.037 DBMET00961 | ||
| 0.101 | 0.017 | 0.101 | 5 Hydroxytryptamine 3 antagonist | 0.058 0.038 DBMET00930 0.058 0.037 DBMET00961 | ||
| 0.104 | 0.022 | 0.104 | T cell inhibitor | 0.098 0.026 DBMET00961 | ||
| 0.12 | 0.039 | 0.138 | Anabolic | 0.125 0.035 DBMET00894 0.138 0.025 DBMET00930 0.118 0.041 DBMET00961 | DBMET00930 | |
| 0.137 | 0.056 | 0.143 | Topoisomerase II inhibitor | 0.095 0.091 DBMET00894 0.1 0.086 DBMET00930 0.143 0.053 DBMET00961 | DBMET00961 | |
| 0.155 | 0.079 | 0.155 | Polo-like kinase-3 inhibitor | 0.127 0.114 DBMET00961 | ||
| 0.099 | 0.024 | 0.099 | 5 Hydroxytryptamine 1B antagonist | 0.058 0.054 DBMET00930 0.064 0.046 DBMET00961 | ||
| 0.094 | 0.02 | 0.124 | Adrenaline uptake inhibitor | 0.073 0.032 DBMET00930 0.124 0.013 DBMET00961 | DBMET00961 | |
| 0.105 | 0.031 | 0.105 | Telomerase inhibitor | 0.083 0.042 DBMET00930 0.081 0.044 DBMET00961 | ||
| 0.111 | 0.039 | 0.143 | Protein kinase C zeta inhibitor | 0.143 0.022 DBMET00930 0.12 0.032 DBMET00961 | DBMET00930 | |
| 0.096 | 0.026 | 0.096 | 5 Hydroxytryptamine 7 antagonist | 0.072 0.036 DBMET00930 0.082 0.03 DBMET00961 | ||
| 0.074 | 0.005 | 0.074 | Nerve growth factor antagonist | 0.065 0.007 DBMET00930 0.055 0.013 DBMET00961 | ||
| 0.14 | 0.073 | 0.148 | Pregnane X receptor agonist | 0.148 0.057 DBMET00930 | DBMET00930 | |
| 0.099 | 0.037 | 0.103 | CYP2A6 inhibitor | 0.072 0.057 DBMET00930 0.103 0.034 DBMET00961 | DBMET00961 | |
| 0.085 | 0.023 | 0.085 | 5 Hydroxytryptamine 3 agonist | 0.057 0.053 DBMET00930 0.065 0.041 DBMET00961 | ||
| 0.115 | 0.055 | 0.115 | MAO A inhibitor | 0.081 0.08 DBMET00961 | ||
| 0.118 | 0.057 | 0.118 | 5 Hydroxytryptamine 3A agonist | |||
| 0.276 | 0.221 | 0.34 | Caspase 9 stimulant | 0.34 0.154 DBMET00894 0.302 0.192 DBMET00930 0.297 0.197 DBMET00961 | DBMET00894 | |
| 0.116 | 0.063 | 0.117 | Photosensitizer | 0.099 0.091 DBMET00930 0.117 0.061 DBMET00961 | DBMET00961 | |
| 0.067 | 0.016 | 0.067 | Dopamine D5 antagonist | 0.06 0.019 DBMET00930 | ||
| 0.089 | 0.038 | 0.089 | Analgesic, opioid | 0.089 0.038 DBMET00930 0.072 0.058 DBMET00961 | ||
| 0.169 | 0.12 | 0.188 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.188 0.1 DBMET00961 | DBMET00961 | |
| 0.074 | 0.028 | 0.085 | Dopamine uptake inhibitor | 0.085 0.023 DBMET00930 0.057 0.041 DBMET00961 | DBMET00930 | |
| 0.206 | 0.163 | 0.249 | Transcription factor NF kappa B inhibitor | 0.245 0.131 DBMET00894 0.249 0.128 DBMET00930 0.213 0.157 DBMET00961 | DBMET00930 | |
| 0.055 | 0.013 | 0.055 | 5 Hydroxytryptamine 3B antagonist | 0.035 0.026 DBMET00930 | ||
| 0.117 | 0.078 | 0.151 | DNA repair enzyme inhibitor | 0.151 0.031 DBMET00894 0.125 0.062 DBMET00930 | DBMET00894 | |
| 0.059 | 0.022 | 0.171 | 5 Hydroxytryptamine 2C agonist | 0.04 0.037 DBMET00930 0.171 0.004 DBMET00961 | DBMET00961 | |
| 0.062 | 0.025 | 0.103 | 5 Hydroxytryptamine 2 agonist | 0.051 0.037 DBMET00930 0.103 0.009 DBMET00961 | DBMET00961 | |
| 0.08 | 0.049 | 0.086 | Estrogen receptor alpha antagonist | 0.086 0.04 DBMET00930 0.073 0.061 DBMET00961 | DBMET00930 | |
| 0.133 | 0.102 | 0.133 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.12 0.116 DBMET00930 0.119 0.117 DBMET00961 | ||
| 0.044 | 0.014 | 0.05 | Integrin alpha1beta1 antagonist | 0.04 0.02 DBMET00930 0.05 0.007 DBMET00961 | DBMET00961 | |
| 0.154 | 0.124 | 0.191 | Platelet aggregation inhibitor | 0.191 0.088 DBMET00961 | DBMET00961 | |
| 0.09 | 0.061 | 0.09 | Glutamate release inhibitor | 0.089 0.064 DBMET00930 | ||
| 0.044 | 0.016 | 0.049 | Opioid delta receptor agonist | 0.039 0.02 DBMET00930 0.049 0.013 DBMET00961 | DBMET00961 | |
| 0.115 | 0.088 | 0.133 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.133 0.075 DBMET00961 | DBMET00961 | |
| 0.071 | 0.045 | 0.09 | Protein kinase C beta inhibitor | 0.09 0.019 DBMET00930 0.071 0.045 DBMET00961 | DBMET00930 | |
| 0.057 | 0.032 | 0.057 | Nicotinic receptor alpha7 subunit antagonist | 0.05 0.043 DBMET00961 | ||
| 0.041 | 0.016 | 0.041 | ATM kinase inhibitor | |||
| 0.093 | 0.068 | 0.095 | Sphingomyelinase inhibitor | 0.095 0.066 DBMET00930 | DBMET00930 | |
| 0.033 | 0.01 | 0.033 | 5 Hydroxytryptamine 1F agonist | 0.025 0.019 DBMET00930 | ||
| 0.173 | 0.149 | 0.245 | 5 Hydroxytryptamine release stimulant | 0.168 0.155 DBMET00930 0.245 0.092 DBMET00961 | DBMET00961 | |
| 0.08 | 0.057 | 0.097 | Acetylcholine nicotinic agonist | 0.097 0.04 DBMET00961 | DBMET00961 | |
| 0.061 | 0.039 | 0.122 | Protein kinase C iota inhibitor | 0.066 0.035 DBMET00930 0.122 0.014 DBMET00961 | DBMET00961 | |
| 0.069 | 0.047 | 0.175 | 5 Hydroxytryptamine agonist | 0.175 0.017 DBMET00961 | DBMET00961 | |
| 0.05 | 0.028 | 0.05 | Farnesyltransferase inhibitor | 0.043 0.036 DBMET00930 | ||
| 0.054 | 0.033 | 0.067 | Estrogen agonist | 0.042 0.041 DBMET00894 0.067 0.027 DBMET00930 0.049 0.036 DBMET00961 | DBMET00930 | |
| 0.078 | 0.058 | 0.078 | Phosphodiesterase 3A inhibitor | |||
| 0.043 | 0.024 | 0.047 | Acid-sensing ion channel blocker | 0.047 0.019 DBMET00930 | DBMET00930 | |
| 0.131 | 0.114 | 0.137 | Heat shock protein 70 antagonist | 0.131 0.117 DBMET00894 0.137 0.086 DBMET00930 | DBMET00930 | |
| 0.079 | 0.063 | 0.079 | Caspase 7 inhibitor | |||
| 0.052 | 0.038 | 0.056 | Opioid agonist | 0.056 0.033 DBMET00930 0.05 0.039 DBMET00961 | DBMET00930 | |
| 0.025 | 0.013 | 0.025 | Dopamine D1 agonist | 0.024 0.015 DBMET00930 0.023 0.015 DBMET00961 | ||
| 0.03 | 0.018 | 0.03 | 5 Hydroxytryptamine 6 agonist | 0.03 0.017 DBMET00961 | ||
| 0.09 | 0.079 | 0.252 | Topoisomerase I inhibitor | 0.252 0.016 DBMET00894 | DBMET00894 | |
| 0.034 | 0.023 | 0.034 | Benzodiazepine receptor peripheral-type antagonist | 0.032 0.029 DBMET00961 | ||
| 0.13 | 0.119 | 0.145 | Ca2+-transporting ATPase inhibitor | 0.145 0.055 DBMET00930 | DBMET00930 | |
| 0.078 | 0.068 | 0.085 | Acetylcholine agonist | 0.085 0.06 DBMET00930 | DBMET00930 | |
| 0.051 | 0.041 | 0.051 | Nicotinic alpha7 receptor agonist | |||
| 0.021 | 0.016 | 0.026 | Alpha 2d adrenoreceptor agonist | 0.026 0.011 DBMET00961 | DBMET00961 | |
| 0.058 | 0.054 | 0.058 | Dopamine agonist | |||
| 0.041 | 0.037 | 0.044 | 5 Hydroxytryptamine 1A agonist | 0.044 0.033 DBMET00961 | DBMET00961 | |
| 0.186 | 0.182 | 0.234 | 5 Hydroxytryptamine uptake stimulant | 0.234 0.099 DBMET00961 | DBMET00961 | |
| 0.038 | 0.034 | 0.072 | Phenylethanolamine N methyltransferase inhibitor | 0.043 0.023 DBMET00930 0.072 0.005 DBMET00961 | DBMET00961 | |
| 0.215 | 0.213 | 0.215 | DNA polymerase beta inhibitor | |||
| 0.138 | 0.136 | 0.151 | P-glycoprotein inhibitor | 0.151 0.116 DBMET00930 | DBMET00930 | |
| 0.035 | 0.034 | 0.035 | DNA-dependent protein kinase inhibitor | |||
| 0.189 | 0.187 | 0.277 | Caspase 3 stimulant | 0.277 0.091 DBMET00930 | DBMET00930 | |
| 0.133 | 0.133 | 0.156 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.156 0.107 DBMET00961 | DBMET00961 | |
| 0.058 | 0.061 | 0.063 | Prolactin release inhibitor | 0.063 0.041 DBMET00930 | DBMET00930 | |
| 0.054 | 0.062 | 0.08 | I kappa B kinase 2 inhibitor | 0.08 0.022 DBMET00961 | DBMET00961 | |
| 0.083 | 0.092 | 0.091 | Nav1.1 sodium channel blocker | 0.091 0.078 DBMET00930 | DBMET00930 | |
| 0.089 | 0.099 | 0.127 | Protein kinase C gamma inhibitor | 0.127 0.047 DBMET00930 | DBMET00930 | |
| 0.078 | 0.09 | 0.085 | MAP kinase kinase kinase inhibitor | 0.085 0.081 DBMET00961 | DBMET00961 | |
| 0.014 | 0.031 | 0.031 | Imidazoline I1 receptor antagonist | 0.031 0.007 DBMET00961 | DBMET00961 | |
| 0.142 | 0.159 | 0.169 | Growth factor agonist | 0.169 0.105 DBMET00930 | DBMET00930 | |
| 0.021 | 0.04 | 0.035 | Endothelial nitric-oxide synthase inhibitor | 0.035 0.017 DBMET00961 | DBMET00961 | |
| 0.039 | 0.063 | 0.052 | Nicotinic neuronal receptor agonist | 0.052 0.043 DBMET00961 | DBMET00961 | |
| 0.034 | 0.059 | 0.045 | Adenylate cyclase 1 inhibitor | 0.045 0.034 DBMET00930 | DBMET00930 | |
| 0.035 | 0.061 | 0.042 | Histamine H1 receptor agonist | 0.042 0.034 DBMET00961 | DBMET00961 | |
| 0.04 | 0.08 | 0.057 | Androgen agonist | 0.057 0.045 DBMET00930 | DBMET00930 | |
| 0.037 | 0.078 | 0.049 | Squalene epoxidase inhibitor | 0.049 0.037 DBMET00930 | DBMET00930 | |
| 0.039 | 0.082 | 0.063 | NMDA 2C receptor antagonist | 0.063 0.042 DBMET00961 | DBMET00961 | |
| 0.072 | 0.116 | 0.103 | Nitric-oxide synthase inhibitor | 0.103 0.054 DBMET00961 | DBMET00961 | |
| 0.033 | 0.079 | 0.048 | Acetylcholine muscarinic agonist | 0.048 0.046 DBMET00930 | DBMET00930 | |
| 0.058 | 0.106 | 0.092 | I kappa B kinase inhibitor | 0.092 0.046 DBMET00961 | DBMET00961 | |
| 0.072 | 0.122 | 0.122 | Adenylate cyclase inhibitor | 0.117 0.07 DBMET00894 0.122 0.066 DBMET00930 | DBMET00930 | |
| 0.061 | 0.113 | 0.097 | Protein kinase (CK2) inhibitor | 0.097 0.066 DBMET00961 | DBMET00961 | |
| 0.125 | 0.181 | 0.183 | Neurotrophic factor enhancer | 0.183 0.094 DBMET00930 | DBMET00930 | |
| 0.007 | 0.064 | 0.036 | Estrogen receptor alpha agonist | 0.036 0.023 DBMET00930 | DBMET00930 | |
| 0.029 | 0.087 | 0.042 | GABA B receptor antagonist | 0.042 0.031 DBMET00961 | DBMET00961 | |
| 0.008 | 0.067 | 0.017 | Alpha 2c adrenoreceptor agonist | 0.017 0.015 DBMET00961 | DBMET00961 | |
| 0.135 | 0.194 | 0.172 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.172 0.105 DBMET00894 0.162 0.121 DBMET00930 | DBMET00894 | |
| 0.021 | 0.082 | 0.063 | Dopamine D5 agonist | 0.063 0.01 DBMET00961 | DBMET00961 | |
| 0.054 | 0.116 | 0.083 | NMDA receptor antagonist | 0.083 0.061 DBMET00961 | DBMET00961 | |
| 0.098 | 0.167 | 0.154 | NOS3 expression enhancer | 0.125 0.107 DBMET00894 0.154 0.068 DBMET00930 | DBMET00930 | |
| 0.062 | 0.136 | 0.093 | Protein kinase (CK2) alpha inhibitor | 0.093 0.083 DBMET00961 | DBMET00961 | |
| 0.092 | 0.169 | 0.142 | CDC-like kinase 4 inhibitor | 0.142 0.108 DBMET00961 | DBMET00961 | |
| 0.082 | 0.16 | 0.113 | Protein kinase C nu inhibitor | 0.113 0.101 DBMET00961 | DBMET00961 | |
| 0.049 | 0.133 | 0.098 | Glycine receptor antagonist | 0.098 0.034 DBMET00930 | DBMET00930 | |
| 0.087 | 0.173 | 0.133 | Neurotrophic factor | 0.133 0.077 DBMET00930 | DBMET00930 | |
| 0.052 | 0.139 | 0.095 | Antineoplastic alkaloid | 0.095 0.051 DBMET00930 | DBMET00930 | |
| 0.108 | 0.2 | 0.156 | Death-associated protein kinase 3 inhibitor | 0.156 0.113 DBMET00961 | DBMET00961 | |
| 0.216 | 0.31 | 0.5 | Antiinflammatory | 0.31 0.206 DBMET00894 0.5 0.087 DBMET00930 | DBMET00930 | |
| 0.094 | 0.193 | 0.139 | Anesthetic general | 0.139 0.126 DBMET00930 | DBMET00930 | |
| 0.065 | 0.2 | 0.194 | Cytidine deaminase inhibitor | 0.194 0.05 DBMET00894 | DBMET00894 | |
| 0.042 | 0.183 | 0.077 | Inducible nitric-oxide synthase inhibitor | 0.077 0.068 DBMET00961 | DBMET00961 | |
| 0.042 | 0.2 | 0.091 | Expectorant | 0.091 0.08 DBMET00894 | DBMET00894 | |
| 0.128 | 0.288 | 0.266 | Antithrombotic | 0.266 0.114 DBMET00894 0.196 0.182 DBMET00930 | DBMET00894 | |
| 0.083 | 0.244 | 0.14 | Adenylate cyclase stimulant | 0.14 0.081 DBMET00961 | DBMET00961 | |
| 0.18 | 0.344 | 0.277 | 5 Hydroxytryptamine release inhibitor | 0.277 0.193 DBMET00961 | DBMET00961 | |
| 0.039 | 0.206 | 0.067 | Glycine receptor agonist | 0.067 0.061 DBMET00930 | DBMET00930 | |
| 0.018 | 0.189 | 0.037 | 5 Hydroxytryptamine 2B agonist | 0.037 0.033 DBMET00961 | DBMET00961 | |
| 0.105 | 0.283 | 0.179 | Superoxide dismutase inhibitor | 0.179 0.143 DBMET00961 | DBMET00961 | |
| 0.029 | 0.208 | 0.06 | Glucosylceramidase inhibitor | 0.06 0.031 DBMET00930 | DBMET00930 | |
| 0.083 | 0.275 | 0.138 | 3C-like protease (Human coronavirus) inhibitor | 0.138 0.125 DBMET00961 | DBMET00961 | |
| 0.038 | 0.231 | 0.08 | ATPase (Vacuolar H+) inhibitor | 0.08 0.079 DBMET00930 | DBMET00930 | |
| 0.036 | 0.266 | 0.111 | GABA C receptor agonist | 0.111 0.056 DBMET00961 | DBMET00961 | |
| 0.1 | 0.334 | 0.206 | Cholesterol antagonist | 0.206 0.16 DBMET00930 | DBMET00930 | |
| 0.112 | 0.357 | 0.232 | Toll-Like receptor 7 agonist | 0.232 0.165 DBMET00894 | DBMET00894 | |
| 0.071 | 0.334 | 0.252 | Antioxidant | 0.252 0.082 DBMET00894 | DBMET00894 | |
| 0.105 | 0.373 | 0.23 | Toll-Like receptor agonist | 0.23 0.167 DBMET00894 | DBMET00894 | |
| 0.087 | 0.362 | 0.252 | Immunosuppressant | 0.252 0.146 DBMET00894 | DBMET00894 | |
| 0.085 | 0.363 | 0.176 | DNA synthesis inhibitor | 0.176 0.159 DBMET00894 | DBMET00894 | |
| 0.015 | 0.296 | 0.058 | Myc inhibitor | 0.058 0.033 DBMET00961 | DBMET00961 | |
| 0.096 | 0.39 | 0.22 | Vasodilator, coronary | 0.22 0.163 DBMET00894 | DBMET00894 | |
| 0.055 | 0.357 | 0.234 | Free radical scavenger | 0.234 0.076 DBMET00894 | DBMET00894 | |
| 0.059 | 0.373 | 0.586 | Tumour necrosis factor alpha release inhibitor | 0.586 0.008 DBMET00930 | DBMET00930 | |
| 0.056 | 0.384 | 0.203 | Hepatoprotectant | 0.203 0.063 DBMET00894 | DBMET00894 | |
| 0.051 | 0.4 | 0.318 | Vasodilator | 0.318 0.042 DBMET00894 | DBMET00894 | |
| 0.004 | 0.415 | 0.032 | Adenosine A1 receptor agonist | 0.032 0.01 DBMET00894 | DBMET00894 | |
| 0.039 | 0.453 | 0.233 | Platelet adhesion inhibitor | 0.233 0.055 DBMET00894 | DBMET00894 | |
| 0.03 | 0.447 | 0.169 | DNA polymerase I inhibitor | 0.169 0.04 DBMET00894 | DBMET00894 | |
| 0.005 | 0.457 | 0.014 | Adenosine A2b receptor agonist | 0.014 0.01 DBMET00894 | DBMET00894 | |
| 0.005 | 0.479 | 0.017 | Adenosine A3 receptor agonist | 0.017 0.012 DBMET00894 | DBMET00894 | |
| 0.072 | 0.546 | 0.246 | Apoptosis antagonist | 0.246 0.132 DBMET00894 | DBMET00894 | |
| 0.053 | 0.542 | 0.303 | Antibacterial | 0.303 0.133 DBMET00894 0.222 0.205 DBMET00930 | DBMET00894 | |
| 0.003 | 0.553 | 0.024 | Purinergic P2X agonist | 0.024 0.021 DBMET00894 | DBMET00894 | |
| 0.005 | 0.592 | 0.057 | Selectin antagonist | 0.057 0.052 DBMET00894 | DBMET00894 | |
| 0.065 | 0.702 | 0.226 | Interleukin 2 agonist | 0.226 0.148 DBMET00930 | DBMET00930 | |
| 0.015 | 0.656 | 0.443 | Angiogenesis stimulant | 0.443 0.016 DBMET00894 | DBMET00894 | |
| 0.009 | 0.707 | 0.081 | Aminoacyl-tRNA synthetase inhibitor | 0.081 0.075 DBMET00894 | DBMET00894 | |
| 0.061 | 0.799 | 0.256 | Peptidyltransferase inhibitor | 0.256 0.047 DBMET00894 | DBMET00894 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |